AI assistant
Sending…
Inotiv, Inc. — Director's Dealing 2019
Feb 12, 2019
34595_dirs_2019-02-12_314cba8f-a105-481f-aff5-91e4f15bccea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-02-08
Reporting Person: Blumhoff Jill (VP, Finance & CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-08 | Employee Stock Option (right to buy) | $1.42 | A | 25000 | Acquired | 2029-02-08 | Common Shares (25000) | Direct |
Footnotes
F1: The option becomes exercisable with respect to 40% of the shares on the first anniversary of the date of grant and with respect to an additional 30% of the shares on each of the second anniversary and the third anniversary of the date of grant, respectively.
More from Inotiv, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 10
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19